Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of in
Author: ["Jonathan B. Rothbard","Sarah Garlington","Qun Lin","Thorsten Kirschberg","Erik Kreider","P. Leo McGrane","Paul A. Wender","Paul A. Khavari"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Many systemically effective drugs such as cyclosporin A are ineffective topically because of their poor penetration into skin. To surmount this problem, we conjugated a heptamer of arginine to cyclosporin A through a pH-sensitive linker to produce R7–CsA. In contrast to unmodified cyclosporin A, which fails to penetrate skin, topically applied R7–CsA was efficiently transported into cells in mouse and human skin. R7–CsA reached dermal T lymphocytes and inhibited cutaneous inflammation. These data establish a general strategy for enhancing delivery of poorly absorbed drugs across tissue barriers and provide a new topical approach to the treatment of inflammatory skin disorders.
Cite this article
Rothbard, J., Garlington, S., Lin, Q. et al. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med 6, 1253–1257 (2000). https://doi.org/10.1038/81359
